Showing 1 to 2 of 2 results


Drug Trial Offers Hope for Acute Myeloid Leukemia Remission
Michelle Gidion, a 56-year-old mother of four, was diagnosed with acute myeloid leukemia after initially ignoring leg bruises. Despite initial treatment failures, a groundbreaking drug trial using bleximenib resulted in her remission, highlighting potential advancements in leukemia treatment.
Drug Trial Offers Hope for Acute Myeloid Leukemia Remission
Michelle Gidion, a 56-year-old mother of four, was diagnosed with acute myeloid leukemia after initially ignoring leg bruises. Despite initial treatment failures, a groundbreaking drug trial using bleximenib resulted in her remission, highlighting potential advancements in leukemia treatment.
Progress
8% Bias Score

BC 007 Fails Long Covid Trial, Subsidiary Files for Insolvency
A clinical trial for the Long Covid drug BC 007 showed negative results, leading to the insolvency of the drug's German subsidiary.

BC 007 Fails Long Covid Trial, Subsidiary Files for Insolvency
A clinical trial for the Long Covid drug BC 007 showed negative results, leading to the insolvency of the drug's German subsidiary.
Progress
0% Bias Score
Showing 1 to 2 of 2 results